| Cell line name | NCI-H69/CPR |
|---|---|
| Synonyms | H69/CPR |
| Accession | CVCL_2137 |
| Resource Identification Initiative | To cite this cell line use: NCI-H69/CPR (RRID:CVCL_2137) |
| Comments | Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP). |
| Sequence variations | Mutation; HGNC; 8975; PIK3CA; Simple; p.Gly106_Arg108del (c.317_325dellGGCAACCGT); Zygosity=Heterozygous (from parent cell line).Mutation; HGNC; 9884; RB1; Simple; p.Glu748Ter (c.2242G>T); ClinVar=VCV000013078; Zygosity=Homozygous (from parent cell line).Mutation; HGNC; 11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Homozygous (from parent cell line). |
| Disease | Lung small cell carcinoma (NCIt: C4917) Small cell lung cancer (ORDO: Orphanet_70573) Derived from metastatic site: Pleural effusion. |
| Species of origin | Homo sapiens (Human)
(NCBI Taxonomy: 9606)
|
| Hierarchy | Parent: CVCL_1579 (NCI-H69) |
| Sex of cell | Male |
| Age at sampling | 55Y |
| Category | Cancer cell line |
| Publications | PubMed=1327513 |
| Cross-references | |
| Cell line collections | ECACC; 96042328 |
| Encyclopedic resources | Wikidata; Q54908104 |
| Entry history | |
| Entry creation | 04-Apr-2012 |
| Last entry update | 20-May-2021 |
| Version number | 17 |